In addition to weight reduction, which may increase with longer treatment duration, GIP agonism appears to enhance insulin sensitivity, blood flow, and adipose tissue storage capacity32 (Table 2)
Its naturally released by cells in your digestive system when you eat, boosting the amount of insulin in your body (to move glucose out of your blood) while inhibiting glucagon (which raises blood sugar levels)
These medications are primarily used to manage type 2 diabetes and, increasingly, obesity, due to their ability to improve blood glucose control and support weight loss
The impact of storage and delivery on the stability of exenatide drug for diabetes therapy
Oftentimes, our hormones are out of whack, particularly during life transitions, which can have downstream effects on neurotransmitters and thus the overall functioning of our nervous system